Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infection

BACKGROUND: Faecal Microbiota Transplant (FMT) has improved outcomes for the treatment of Clostridioides difficile infection (CDI) compared to antibiotic therapy. FMT is classified as a medicinal product in the United Kingdom, similar to the USA and Canada, limiting supply via stool banks without ap...

Descripción completa

Detalles Bibliográficos
Autores principales: McCune, V.L., Quraishi, M.N., Manzoor, S., Moran, C.E., Banavathi, K., Steed, H., Massey, D.C.O, Trafford, G.R, Iqbal, T.H., Hawkey, P.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152830/
https://www.ncbi.nlm.nih.gov/pubmed/32300746
http://dx.doi.org/10.1016/j.eclinm.2020.100301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152830/
https://www.ncbi.nlm.nih.gov/pubmed/32300746
http://dx.doi.org/10.1016/j.eclinm.2020.100301

Ejemplares similares